Delisting, Listing Rule Failure, or Listing Transfer

Skillz Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Skillz Inc. on September 25, 2025. The filing addresses the Company's status regarding its listing on the New York Stock Exchange (NYSE) following a failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance and listing status rather than financial performance data.

Material Changes and Listing Status

  • Delisting Notice: On April 2, 2025, the NYSE notified Skillz of non-compliance with Section 802.01E of the Listed Company Manual due to the late filing of the 2024 Form 10-K.
  • Initial Cure Period: The NYSE initially granted a six-month period to regain compliance.
  • Extension Granted: On September 25, 2025, the NYSE granted an "Additional Cure Period," extending the listing deadline to December 17, 2025.
  • Conditions: Continued listing is contingent upon the Company becoming current with all delayed SEC filings (2024 Form 10-K and Q1/Q2 2025 Form 10-Qs) by the new deadline.

Outlook, Risks, and Management Commentary

Management expects to complete and file the delayed reports in advance of the December 17, 2025 deadline. The filing includes significant forward-looking statements and risk factors, including:

  • The ability to sustain profitability if revenue continues to decline.
  • Challenges in competing within the global entertainment and gaming industries.
  • Risks related to third-party developer relationships and brand awareness.
  • Issues regarding artificial intelligence and machine learning development.
  • The need to remediate material weaknesses in internal controls over financial reporting identified in fiscal year 2025.

Investor Verification Checklist

  • Verify the filing status of the 2024 Form 10-K and Q1/Q2 2025 Form 10-Qs on the SEC EDGAR database before December 17, 2025.
  • Monitor for any further communications from the NYSE regarding the Company's compliance with the Additional Cure Period.
  • Review the Company's upcoming filings for details on the remediation of material weaknesses in internal controls.
  • Assess the impact of potential revenue declines on the Company's long-term profitability as noted in the risk factors.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.